• Axel Schmutz, Thorsten Dürk, Marco Idzko, Thomas Koehler, Johannes Kalbhenn, and Torsten Loop.
• Department of Anesthesiology and Intensive Care Medicine, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg im Breisgau, Germany. Electronic address: axel.schmutz@uniklinik-freiburg.de.
• J. Cardiothorac. Vasc. Anesth. 2017 Aug 1; 31 (4): 1343-1347.

ObjectivesTo determine the feasibility of a supraglottic airway device for transbronchial cryobiopsy in adults.DesignRetrospective analysis of anesthetic and pulmonary records between March 2015 and August 2016.SettingSingle university medical center.ParticipantsOne hundred thirty-two patients who underwent transbronchial cryobiopsy procedures performed under general anesthesia.InterventionsNot applicable.Measurements And Main ResultsFailure-free use of a supraglottic airway device was 96.8%. Failure of supraglottic airway device insertion was 3.1% because of impossible placement (n = 1), high oropharyngeal leakage (n = 1), massive bleeding requiring bronchial blocker (n = 1), and acute right heart failure with cardiac arrest requiring resuscitation (n = 1). No serious adverse events due to the supraglottic airway device were observed.ConclusionThe data demonstrated that transbronchial cryobiopsy under general anesthesia and airway management with a supraglottic airway device was a feasible technique.Copyright © 2017 Elsevier Inc. All rights reserved.

35 keywords...

hide…